RCKT icon

Rocket Pharmaceuticals

146 hedge funds and large institutions have $1.85B invested in Rocket Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

32% less capital invested

Capital invested by funds: $2.74B → $1.85B (-$888M)

Holders
146
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.68M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$44.4M
2 +$24.1M
3 +$17.3M
4
NHAS
Novo Holdings A/S
Denmark
+$16M
5
Citadel Advisors
Citadel Advisors
Florida
+$15M

Top Sellers

1 -$39.8M
2 -$26.1M
3 -$15.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$14M
5
PA
Perceptive Advisors
New York
-$13.2M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$797K
77
$666K
78
$643K
79
$638K
80
$623K
81
$616K
82
$616K
83
$562K
84
$538K
85
$519K
86
$513K
87
$500K
88
$500K
89
$460K
90
$439K
91
$419K
92
$394K
93
$394K
94
$366K
95
$332K
96
$325K
97
$310K
98
$307K
99
$303K
100
$302K